Cargando…

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?

Detalles Bibliográficos
Autor principal:	Ghanei, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959088/ https://www.ncbi.nlm.nih.gov/pubmed/33747291 http://dx.doi.org/10.5114/aoms/130647

Ejemplares similares

Finding the right time for anti-inflammatory therapy in COVID-19
por: de Simone, Giovanni, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Poor responders: Is it time to consider changing the nomenclature?
por: Chittawar, Priya Bhave, et al.
Publicado: (2012)

Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?
por: Redant, Sébastien, et al.
Publicado: (2021)

When is the “Right” Timing?
por: Chua, Marvin Wei Jie
Publicado: (2021)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Leech therapy and infection control: No clear window
por: Senthilkumaran, Subramanian, et al.
Publicado: (2014)

Radiotherapy treatment scheduling considering time window preferences
por: Vieira, Bruno, et al.
Publicado: (2020)

The emergence of mumps after the COVID-19 pandemic in Pakistan: Time to consider MMR vaccination strategies
por: Rana, Muhammad Suleman, et al.
Publicado: (2023)

Time Matters!: When is the Right Time to Estimate Serum Valproic Acid Levels?
por: Damegunta, Swetha Reddy
Publicado: (2014)

Impact of expanding large vessel occlusion thrombectomy time-windows in inner city Detroit
por: Rajah, Gary B, et al.
Publicado: (2018)

Right Place, Right Time: Serendipitous Opportunities in a Urology Fellowship Disrupted by the COVID-19 Pandemic
por: Chowdhury, Md Ashif, et al.
Publicado: (2020)

Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle
por: Cay, Serkan, et al.
Publicado: (2014)

Epidemic-Logistics Network Considering Time Windows and Service Level
por: Liu, Ming, et al.
Publicado: (2019)

COVID-19 in Chemical Lung Injury Cases
por: Jafari, Ramezan, et al.
Publicado: (2021)

Considering Personalized Interferon Beta Therapy for COVID-19
por: Dorgham, Karim, et al.
Publicado: (2021)

Towards ‘Single window therapy model’
por: Sridhar, K. R.
Publicado: (2010)

Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
por: Razanamahery, J., et al.
Publicado: (2020)

Is there a place for anti-inflammatory therapy in COVID-19?
por: Yew, Wing Wai, et al.
Publicado: (2020)

Radionuclide therapy in the time of COVID-19
por: Brabander, Tessa, et al.
Publicado: (2020)

Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease
por: Mahmoudi, Morteza
Publicado: (2014)

Extrapulmonary effects of nitric oxide inhalation therapy: time to consider new dosing regimes?
por: Lundberg, Jon O, et al.
Publicado: (2008)

Anti-viral properties of antipsychotic medications in the time of COVID-19
por: Girgis, Ragy R., et al.
Publicado: (2021)

Time to consider sequencing anti-inflammatory treatments with chemotherapy and immuno-stimulation?
por: Blanck, George
Publicado: (2022)

Time to consider neuroinflammation as a booster effect of cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia?
por: Marchandot, Benjamin, et al.
Publicado: (2021)

The lungs and drug delivery
por: Shohrati, Majid, et al.
Publicado: (2012)

Perspective in future pharmacological approach to sulfur mustard lung injuries
por: Saburi, Amin, et al.
Publicado: (2012)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Time-related aortic inflammatory response in severely or critical COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection
por: Copin, Marie-Christine, et al.
Publicado: (2020)

COVID-19 and Right to Die With Dignity: Time to Re-Evaluate Policies Over the Practice of Last Rites?
por: Menon, Vikas, et al.
Publicado: (2020)

Arrhythmogenic Right Ventricle in Left Ventricular Non-compaction - In Response to the Letter to the Editor "Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle"
por: Honarbakhsh, Shohreh, et al.
Publicado: (2014)

Comments: Other considerations about surgery in lung cancer
por: Ghanei, Mostafa, et al.
Publicado: (2012)

Right middle cerebral artery aneurysm posted for clipping on dual anti-platelet therapy
por: Parida, Satyen, et al.
Publicado: (2010)

Nasal or Nasopharyngeal Tuberculosis Should be Considered in the Initial Diagnosis of Sino-Nasal Inflammatory Diseases
por: Min, Hyun Jin, et al.
Publicado: (2017)

A Positive Reflux-Symptom Association Is Not Marked When the Onset of the Reflux Episode Does Not Occur Within the Pre-symptom Time Window
por: Woodley, Frederick W
Publicado: (2018)

Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
por: Davoudi-Monfared, Effat, et al.
Publicado: (2021)

Dental dam: the time is right
por: Emery, C.
Publicado: (2020)

Presentation and pathophysiology of neuro-COVID
por: Finsterer, Josef, et al.
Publicado: (2021)

Time to assess the effects of sodium–glucose co‐transporter‐2 inhibitors on the ‘forgotten' right ventricle?
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8d7ji0ttli4t77ke1db3qjldnu